Shenzhen Fifth People's Hospital
3 clinical trials · Sponsor
◉ Watch Shenzhen Fifth People's Hospital
| Record | Firm | Date |
|---|---|---|
| An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects (NCT05277987) | Shenzhen Fifth People's Hospital | 2022-03-01 |
| The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol (NCT03777930) | Shenzhen Fifth People's Hospital | 2018-12-10 |
| Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation (NCT03662477) | Shenzhen Fifth People's Hospital | 2018-01-01 |
Track Shenzhen Fifth People's Hospital automatically
Every clearance here is in the API, with alerts when new ones post.